NIH-funded research R21 grant

How HIV's Nef protein makes the virus more infectious even without SERINC

Official title: Basis of Serinc-Independent Enhancement of Infectivity by HIV-1Nef

Funded at Veterans Medical Research Fdn/san Diego · NIH-11253295 · Data updated 2026-11-12

Researchers are searching for the missing protein or pathway that lets the HIV protein Nef boost virus infectivity, with the goal of helping people living with HIV.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionVeterans Medical Research Fdn/san Diego
NIH-funded
Lab location1 site (San Diego, United States)
Project startJanuary 3, 2025
Project endDecember 31, 2026
Funding year2026
Award (this year)$184,375
NIH project number5R21AI189232-02
Project IDNIH-11253295 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be adults living with HIV who are willing to donate blood or immune cells for laboratory research, typically near San Diego.

Less likely to help

People without HIV or those not able or willing to provide samples are unlikely to receive direct benefit from this laboratory-focused project.

What this research studies

This lab project looks at how the HIV protein Nef increases the ability of the virus to infect cells even when known inhibitors like SERINC proteins are not responsible. The team will use proximity-proteomics and other molecular tools in T cell lines and likely primary CD4+ T cells to find proteins or pathways that interact with Nef. The work is open-ended and exploratory, aiming to identify previously unknown factors that explain Nef's effect on viral infectivity. Because this is bench research, the project may request blood or immune-cell samples from donors rather than running a clinical treatment trial.

Why it matters

Potential benefit: If successful, the project could uncover new drug targets to block Nef-driven increases in HIV infectivity and inform future therapies.

How similar studies have gone: Similar proteomics approaches have previously identified factors like SERINC5 and other Nef partners, but the SERINC-independent mechanism this project targets remains novel and unresolved.

Where this research is happening

  • Veterans Medical Research Fdn/san Diego
    San Diego, United States
    Active

Researchers

  • Principal investigator: Guatelli, John C. — Veterans Medical Research Fdn/san Diego
  • Study coordinator: Guatelli, John C.

Related research

Other NIH-funded projects on the same topics.

  • PSA Screening: Understanding Benefits and Risks for Black Men

    This grant studies how PSA screening affects Black men to help tailor guidelines and decision-making.

    NIH research Veterans Medical Research Fdn/san Diego · San Diego, United States · NIH-11428699

  • Medial Prefrontal Cortex and Alcohol Relapse in Humans

    A study aims to understand brain factors in relapse to drinking alcohol after abstinence, focusing on the medial prefrontal cortex and blood-brain barrier changes in adults with alcohol use disorder.

    NIH research Veterans Medical Research Fdn/san Diego · San Diego, United States · NIH-11395370

  • How BST2 variants affect HIV defense and help the virus

    This grant studies how HIV tricks the body’s BST2/tetherin defenses and what that means for HIV staying in your body and spreading.

    NIH research Veterans Medical Research Fdn/san Diego · San Diego, United States · NIH-11370701

  • Kidney tubule function and APOL1 in African ancestry people

    A study to understand how kidney tubule health markers relate to kidney disease risk in African ancestry individuals with APOL1 variants.

    NIH research Veterans Medical Research Fdn/san Diego · San Diego, United States · NIH-11364368

  • How breathing machines can harm the kidneys

    Doctors will look at how ventilators change kidney filtering and salt handling in people who are critically ill to help prevent kidney damage.

    NIH research Veterans Medical Research Fdn/san Diego · San Diego, United States · NIH-11349714

  • How SGLT2-blocking diabetes drugs affect kidney filtering and tubule function

    This research looks at how SGLT2-blocking diabetes medicines change tiny blood vessels, tubules, and metabolism inside diabetic kidneys to explain how they slow kidney disease.

    NIH research Veterans Medical Research Fdn/san Diego · San Diego, United States · NIH-11324539

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.